XILIO THERAPEUTICS INC shareholders Q3 2023

XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 32 filers reported holding XILIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

XILIO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,441,444$3,041,4477.52%
Trustees of Columbia University in the City of New York 249,635$526,7300.97%
Atlas Venture Life Science Advisors, LLC 2,759,344$5,822,2160.90%
Octagon Capital Advisors LP 2,318,500$4,892,0350.75%
Bain Capital Life Sciences Investors, LLC 2,805,413$5,919,4210.66%
HARVARD MANAGEMENT CO INC 416,059$8780.10%
Rock Springs Capital Management LP 1,440,759$3,040,0010.08%
Soleus Capital Management, L.P. 226,941$478,8460.04%
Artal Group S.A. 450,000$9500.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,481$233,1150.01%
Laurion Capital Management LP 139,260$293,8390.00%
FIL Ltd 218,705$461,4680.00%
Key FInancial Inc 830$1,7510.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11,925$25,1620.00%
MORGAN STANLEY 26,265$55,4190.00%
BlackRock Inc. 47,384$99,9810.00%
Qube Research & Technologies Ltd 4$80.00%
Tower Research Capital LLC (TRC) 3,882$8,1910.00%
JPMORGAN CHASE & CO 2,722$5,7430.00%
Renaissance Technologies 20,700$440.00%

This page lists XILIO THERAPEUTICS INC's shareholders in Q3 2023. To view XILIO THERAPEUTICS INC's shareholder history, click here.